EVH
Evolent Health Inc - Class A
$34.36
Earnings Summary
Revenue | $319.94Mn |
Net Profits | $-4.59Mn |
Net Profit Margins | -1.43% |
Highlights
Evolent Health Inc - Class A’s revenue jumped 44.08% since last year same period to $319.94Mn in the Q2 2022. On a quarterly growth basis, Evolent Health Inc - Class A has generated 7.7% jump in its revenue since last 3-months.
Evolent Health Inc - Class A’s net profit jumped 49.62% since last year same period to $-4.59Mn in the Q2 2022. On a quarterly growth basis, Evolent Health Inc - Class A has generated 14.24% jump in its net profits since last 3-months.
Evolent Health Inc - Class A’s net profit margin jumped 65.03% since last year same period to -1.43% in the Q2 2022. On a quarterly growth basis, Evolent Health Inc - Class A has generated 20.38% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Evolent Health Inc - Class A post its latest quarter earnings
EPS Estimate Current Quarter | 0.05 |
EPS Estimate Current Year | 0.05 |
Highlights
Evolent Health Inc - Class A’s earning per share (EPS) estimates for the current quarter stand at 0.05 - a 150% jump from last quarter’s estimates.
Evolent Health Inc - Class A’s earning per share (EPS) estimates for the current year stand at 0.05.
Key Ratios
Key ratios of the Evolent Health Inc - Class A post its Q2 2022 earnings
Earning Per Share (EPS) | 0.1 |
Return on Assets (ROA) | 0 |
Return on Equity (ROE) | -0.03 |
Dividend Per Share (DPS) | 0 |
Highlights
Evolent Health Inc - Class A’s earning per share (EPS) jumped 600% since last year same period to 0.1 in the Q2 2022. This indicates that the Evolent Health Inc - Class A has generated 600% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Evolent Health Inc - Class A’s return on assets (ROA) stands at 0.
The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Evolent Health Inc - Class A’s return on equity (ROE) stands at -0.03.
Evolent Health Inc - Class A declared 0 dividend per share during the earnings announcement for Q2 2022.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2022-05-05 | 0.02 | 0.12 | 500% |
2022-06-30 | 0.05 | 0.1 | 100% |
Company Information
Evolent Health delivers proven clinical and administrative solutions that improve whole-person health while making health care simpler and more affordable. Its solutions encompass total cost of care management, specialty care management, and administrative simplification. Evolent serves a national base of leading payers and providers, is the first company to receive the National Committee for Quality Assurance's Population Health Program Accreditation, and is consistently recognized as a top place to work in health care nationally.
Organisation | Evolent Health Inc - Class A |
Headquarters | Arlington, Virginia, US |
Employees | 2.9K |
Industry | Miscellaneous Commercial Services |
CEO | Frank Williams |